Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AXNX

Axonics (AXNX)

Axonics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AXNX
DateTimeSourceHeadlineSymbolCompany
04/30/20243:01PMBusiness WireAxonics Reports First Quarter 2024 Financial ResultsNASDAQ:AXNXAxonics Inc
04/24/20245:30AMPR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NASDAQ:AXNXAxonics Inc
03/22/20243:01PMBusiness WireAxonics Stockholders Approve Merger Agreement with Boston ScientificNASDAQ:AXNXAxonics Inc
03/21/20243:54PMBusiness WireAxonics Provides Update on Inter Partes Review ProceedingsNASDAQ:AXNXAxonics Inc
03/14/20245:00AMBusiness WireAxonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
03/07/20244:24PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AXNXAxonics Inc
02/29/20243:01PMBusiness WireAxonics Responds to ITC Action by MedtronicNASDAQ:AXNXAxonics Inc
02/28/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
02/28/20243:01PMBusiness WireAxonics Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
02/22/20247:00AMEdgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AXNXAxonics Inc
02/02/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
02/02/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
02/02/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
02/02/20244:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
01/31/20245:30AMPR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NASDAQ:AXNXAxonics Inc
01/10/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
01/10/20242:07PMPR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AXNXAxonics Inc
01/08/20244:19PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXNXAxonics Inc
01/08/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
01/08/20243:55PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NASDAQ:AXNXAxonics Inc
01/08/202410:36AMDow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNASDAQ:AXNXAxonics Inc
01/08/20247:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
01/08/20246:41AMDow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNASDAQ:AXNXAxonics Inc
01/08/20246:00AMPR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NASDAQ:AXNXAxonics Inc
01/08/20246:00AMBusiness WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNASDAQ:AXNXAxonics Inc
01/08/20246:00AMBusiness WireAxonics Reports Preliminary 4Q23 and Fiscal Year 2023 RevenueNASDAQ:AXNXAxonics Inc
12/28/20236:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
12/27/20233:01PMBusiness WireAxonics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:AXNXAxonics Inc
12/26/202312:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXNXAxonics Inc
11/06/202311:00AMGlobeNewswire Inc.Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual DisabilitiesNASDAQ:AXNXAxonics Inc
 Showing the most relevant articles for your search:NASDAQ:AXNX